· ASX-listed global cannabis company with rapidly expanding operations in Europe, North America, Australia and Africa

· Vertically integrated with capabilities spanning the manufacturing, sales and distribution of pharmaceutical and non-pharmaceutical cannabis-based products

· Strong financial performance, news flow, and cash position

· Massive market opportunity - undervalued against peer group

Althea Group Holdings Ltd CEO, Joshua Fegan, said: "We are currently focused on strategically growing our footprint across the UK, Germany and other key European regions, including France, where we have recently been selected as a supplier for the French government's upcoming medicinal cannabis trial. With Europe expected to become the world's largest legal cannabis market over the next five years, we believe there has never been a more compelling and opportunistic time to be an Althea shareholder." 

https://www.share-talk.com/joshua-fegan-ceo-managing-director-of-althea-group-hldgs-agh-asx-interview/